Curanex Pharmaceuticals (CURX) Total Current Liabilities (2024 - 2026)

Curanex Pharmaceuticals (CURX) has reported Total Current Liabilities for 3 consecutive years, with $104306.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Current Liabilities rose 37.38% year-over-year to $104306.0; the trailing twelve-month figure through Jun 2026 stood at $104306.0 (up 37.38% YoY), and the FY2025 full-year result was $137030.0, up 840.17% from the prior year.
• Total Current Liabilities retreated to $104306.0 in Q2 2026 per CURX's latest filing, from $137030.0 in the prior quarter.
• Across five years, Total Current Liabilities topped out at $185955.0 in Q3 2025 and bottomed at $14575.0 in Q4 2024.
• Historically, Total Current Liabilities has averaged $103558.6 across 3 years, with a median of $104306.0 in 2026.
• The sharpest annual moves came in 2025 and 2026: Total Current Liabilities jumped 840.17% in 2025, then jumped 37.38% in 2026.
• Over 3 years, Total Current Liabilities stood at $14575.0 in 2024, then surged by 840.17% to $137030.0 in 2025, then retreated by 23.88% to $104306.0 in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $104306.0, $137030.0, and $185955.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.